Affiliation:
1. Department of Medical Biochemistry, Medical University of Lodz, Lodz, Poland
2. Laboratory of Medical Genetics, Faculty of Biology and Environmental Protection, University of Lodz, Lodz, Poland
Abstract
AbstractOver the past two decades, extensive research has been done to elucidate the molecular etiology and pathophysiology of neuropsychiatric disorders. In majority of them, including Alzheimer’s disease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), bipolar disorder (BD), schizophrenia and major depressive disorder, increased oxidative and nitrosative stress was found. This stress is known to induce oxidative damage to biomolecules, including DNA. Accordingly, increased mitochondrial and nuclear DNA, as well as RNA damage, were observed in patients suffering from these diseases. However, recent findings indicate that the patients are characterised by impaired DNA repair pathways, which may suggest that these DNA lesions could be also a result of their insufficient repair. In the current systematic, critical review, we aim to sum up, using available literature, the knowledge about the involvement of nuclear and mitochondrial DNA damage and repair, as well as about damage to RNA in pathoetiology of neuropsychiatric disorders, i.e., AD, PD, ALS, BD, schizophrenia and major depressive disorder, as well as the usefulness of the discussed factors as being diagnostic markers and targets for new therapies. Moreover, we also underline the new directions to which future studies should head to elucidate these phenomena.
Funder
Polish National Science Centre
Publisher
Oxford University Press (OUP)
Subject
Health, Toxicology and Mutagenesis,Genetics(clinical),Toxicology,Genetics
Reference332 articles.
1. Economic burden of the therapeutic management of mental illnesses and its effect on household purchasing power;Agboola;PLoS One,,2018
2. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study;Murray;Lancet,,1997
3. Progress in Alzheimer’s disease drug discovery: an update;Williams;Curr. Opin. Investig. Drugs,,2009
4. Epidemiology of Parkinson’s disease;de Lau;Lancet. Neurol.,,2006
5. Population prevalence and incidence of Parkinson’s disease in an Australian community;Mehta;Intern. Med. J.,,2007
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献